The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation.
By Bo Zhong, Yan Yang, Shu Li, Yan-Yi Wang, Y. Li, Feici Diao, Caoqi Lei, Xiao He, Lu Zhang, P. Tien and 1 more. Immunity, 2008
1,497 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/1f7cb63e9e261cd3b09e997d706719dcd16d39c6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- Zhijian J. Chen
- G. Barber
- Shizuo Akira
- T. Mogensen
- Tuo Li
- A. Ablasser
- Katherine A. Fitzgerald
- T. Abe
In Molecular Biology
Citations in the corpus
- ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization (2009, neutral): “(28) from Shu’s group, and as ‘‘MPYS’’ by Jin et al.”
- RNA recognition and signal transduction by RIG‐I‐like receptors (2009, background): “In this context, mediator of IRF-3 activation (MITA), also known as stimulator of interferon genes (STING), was identified as a critical scaffold protein for IRF-3 activation (86, 87).”
- The innate immune DNA sensor cGAS produces a non-canonical cyclic-di-nucleotide that activates human STING (2013, background): “An endoplasmic-reticulum-resident host protein called stimulator of IFN genes (STING; also called TMEM173, MITA, ERIS, and MPYS) was shown to be required for IFN response to cytosolic dsDNA (Ishikawa and Barber, 2008; Ishikawa et al., 2009; Sun et al., 2009; Zhong et al., 2008).”
- Innate Immune Pattern Recognition: A Cell Biological Perspective (2015, neutral): “Reports of STING on mitochondria and the MAM may be due to the dynamic interactions between these organelles as described above (228, 230).”
- The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. (2014, background): “Cytosolic DNA induces type I IFNs through the endoplasmic reticulum membrane protein STING, which subsequently activates the transcription factors NF-kB and IRF3 through the kinases IKK and TBK1, respectively (Ishii et al., 2006; Ishikawa and Barber, 2008; Ishikawa et al., 2009; Stetson and Medzhito”